In turn, overexpression of miR-100 showed increased sensitivity to CIS due to modulation of the HCLS1-associated protein X-1(HAX-1), an inhibitor of mitochondrial apoptosis that maintains mitochondrial membrane potential in cancer cells [148]. The gene discussed is HAX1; the disease is in situ carcinoma.